| |
| |
|
| Insider
Information: |
Funck Robert E |
| Relationship: |
|
| City: |
Abbott Park |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
211,341 |
|
|
Indirect Shares
|
59,265 |
|
|
| Direct
Value |
$22,381,012 |
|
|
|
Indirect Value
|
$6,276,164 |
|
|
| Total
Shares |
270,606 |
|
|
| Total
Value |
$28,657,175 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 41.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Abbott Laboratories |
ABT |
|
2024-02-29 |
211,341 |
2024-02-29 |
59,265 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2024-02-29 |
4 |
D |
$120.05 |
$1,370,371 |
D/D |
(11,415) |
211,341 |
0 |
- |
|
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2024-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
24,519 |
222,756 |
0 |
- |
|
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2023-09-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
20,000 |
20,000 |
0 |
- |
|
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2023-09-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,000 |
198,237 |
0 |
- |
|
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2023-03-01 |
4 |
S |
$100.70 |
$127,285 |
D/D |
(1,264) |
218,237 |
0 |
% |
|
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2023-02-28 |
4 |
D |
$99.77 |
$1,147,355 |
D/D |
(11,500) |
219,501 |
0 |
- |
|
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2023-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
24,419 |
231,001 |
0 |
- |
|
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2022-02-28 |
4 |
D |
$122.41 |
$1,315,908 |
D/D |
(10,750) |
206,582 |
0 |
- |
|
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2022-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
28,682 |
217,332 |
0 |
- |
|
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2021-04-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
700 |
188,650 |
0 |
- |
|
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2021-02-26 |
4 |
D |
$121.58 |
$1,232,335 |
D/D |
(10,136) |
189,350 |
0 |
- |
|
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2021-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
24,185 |
199,486 |
0 |
- |
|
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2021-02-02 |
4 |
D |
$122.54 |
$2,235,252 |
D/D |
(18,241) |
175,301 |
0 |
- |
|
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2021-02-02 |
4 |
OE |
$39.12 |
$1,225,434 |
D/D |
31,325 |
193,542 |
0 |
- |
|
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2020-12-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,000 |
162,217 |
0 |
- |
|
| ABT |
Abbott Laboratories |
EXECUTIVE VICE PRESIDENT |
• – – |
2020-12-15 |
4 |
GA |
$0.00 |
$0 |
I/I |
20,000 |
10,000 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President & CFO |
• – – |
2020-10-26 |
4 |
S |
$108.83 |
$9,068,955 |
D/D |
(83,333) |
182,217 |
0 |
% |
|
| ABT |
Abbott Laboratories |
Executive Vice President & CFO |
• – – |
2020-10-26 |
4 |
OE |
$38.40 |
$3,199,987 |
D/D |
83,333 |
265,550 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President & CFO |
• – – |
2020-04-21 |
4 |
D |
$98.00 |
$2,337,790 |
D/D |
(23,855) |
182,217 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President & CFO |
• – – |
2020-04-21 |
4 |
OE |
$34.94 |
$1,336,638 |
D/D |
36,700 |
206,072 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President & CFO |
• – – |
2020-03-02 |
4 |
S |
$77.89 |
$105,619 |
D/D |
(1,356) |
169,372 |
0 |
% |
|
| ABT |
Abbott Laboratories |
Executive Vice President & CFO |
• – – |
2020-02-28 |
4 |
D |
$79.19 |
$531,365 |
D/D |
(6,710) |
170,728 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2020-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
25,265 |
177,438 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2019-08-09 |
4 |
D |
$85.56 |
$2,294,548 |
D/D |
(26,818) |
152,173 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Senior Vice President |
• – – |
2019-08-09 |
4 |
OE |
$34.94 |
$1,397,600 |
D/D |
40,000 |
178,991 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
